Affimed appoints Shawn Leland as chief executive officer

  • Affimed N.V. (NASDAQ:AFMD) has announced that Shawn M. Leland, PharmD, RPh has been appointed as Chief Executive Officer (CEO).
  • Dr. Andreas Harstrick, acting CEO since January 2024 will continue in his position as Chief Medical Officer (CMO).
  • Most recently, Shawn was the Interim CEO and Board Director of ForeBio.
  • Source: Press Release

Leave a Reply

Your email address will not be published. Required fields are marked *